Pre-Treatment and Post-Treatment Anxiety, Depression, Sleep and Sexual Function Levels in Patients with Breast Cancer
Pre-Treatment and Post-Treatment Anxiety, Depression, Sleep and Sexual Function Levels in Patients with Breast Cancer
复制标题
DOI：
10.5152/ejbh.2020.5259
复制
发表时间：
2020-07-01
影响因子：
1.6
通讯作者：
Ozmen, Vahit
中科院分区：
文献类型：
--
作者：
Izci, Filiz;Ozdem, Gozdem;Ozmen, Vahit
目的：在乳腺癌病例的诊断和治疗阶段，患者通常会出现性功能障碍、睡眠障碍和精神障碍，如焦虑和抑郁。本研究的主要目的是探讨乳腺癌患者治疗前后的焦虑、抑郁、睡眠及性功能水平。材料与方法：选取五十六例乳腺癌患者和52例健康妇女作为研究对象。以确定焦虑，抑郁。睡眠和性功能水平，社会人口学和临床数据表，医院焦虑抑郁量表（HADS）。采用匹兹堡睡眠质量量表（PSQI）和亚利桑那性经验量表（ASEX）对乳腺癌患者和对照组在治疗前后进行评分。根据应用于患者和对照组的量表评分，已经确定患有乳腺癌HADS的患者性和睡眠障碍，HADS和PSQI评分较高，ASEX评分显著降低（p
Objective: In the phase of diagnosis and treatment of breast cancer cases, patients can usually experience sexual dysfunctions, sleep disorders and psychiatric disorders such as anxiety and depression. The main objective of our research is to study of the pre-treatment and post-treatment anxiety, depression, sleep and sexual function levels in the patients with breast cancer.Materials and Methods: Fifty-six patients with breast cancer and 52 healthy women have participated in our study. In order to determine the anxiety, depression. sleep and sexual function levels, Sociodemographic and Clinical Data Form, Hospital Anxiety Depression Scale (HADS). Pittsburgh Sleep Quality Scale (PSQI) and Arizona Sexual Experiences Scale (ASEX) scores are utilized at pre-treatment and post-treatment phases for patients with breast cancer and our control group.Results: According to scale scores applied to patients and control group, it has been determined that patients with breast cancer HADS sexual and sleep disorders, that their HADS and PSQI scores were higher and that ASEX scores decreased significantly (p